Stock listing
Dare Bioscience, Inc.
Selected listing: DARE · NASDAQ · USD · US
Dare Bioscience, Inc. (NASDAQ:DARE), Health Technology. Latest release Sep 28, 2026: Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program…
- Ticker
- NASDAQ:DARE
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Dare Bioscience, Inc.
Dare Bioscience, Inc. is a public company listed under the ticker DARE, operating in the American market. Dare Bioscience focuses on developing innovative products in women's health.
Latest news from Dare Bioscience, Inc.
Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program as a Potential First FDA-Approved Pharmacologic Treatment for HPV Infection
September 28, 2026
Daré Bioscience Announces Peer-Reviewed Publication of Phase 1 Sildenafil Cream Study in Men Demonstrating Substantially Lower Systemic Exposure Versus Oral Sildenafil
September 14, 2026
Daré Bioscience Presentation for H.C. Wainwright 28th Annual Global Investment Conference Now Available On-Demand
September 11, 2026
Daré Bioscience Announces New NIH Funding Award for Approximately $908,000 to Advance DARE-PTB2 for the Prevention of Preterm Birth
August 31, 2026
Daré Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor “Why Now” On-Demand Series
August 27, 2026
Events
Research Dare Bioscience, Inc.
Dare Bioscience, Inc. company profile
View the public company page for Dare Bioscience, Inc. on 6ix.
Dare Bioscience, Inc. news
Read company news and market updates connected to Dare Bioscience, Inc..
Dare Bioscience, Inc. investor events
Find investor webinars, events, and replay context for Dare Bioscience, Inc..